Medicines Marketed by Ajanta Pharma Ltd

About Ajanta Pharma Ltd

Ajanta Pharma Ltd, established in 1973, is a renowned Indian pharmaceutical company with over 51 years of experience in developing, manufacturing, and marketing pharmaceutical formulations. Headquartered in Mumbai, Maharashtra, the company has a significant global presence, with its products distributed across more than 30 countries, including Africa, South East Asia, West Asia, and the Commonwealth of Independent States (CIS). Ajanta Pharma also has a strong foothold in the United States, particularly in the generics market.

Ajanta Pharma serves a diverse consumer base, catering to healthcare professionals and patients worldwide. In India, the company focuses on branded generics, particularly in therapeutic areas such as cardiology, dermatology, ophthalmology, and pain management. In emerging markets, it offers a broader range of therapeutic products, while in the USA, it specialises in generic medications.

Ajanta Pharma Ltd Products

Ajanta Pharma Ltd manufactures a wide range of pharmaceutical products, including branded generics in India and emerging markets, generics in the USA, and Active Pharmaceutical Ingredients (APIs). The company is a leader in branded generics in India, focusing on high-growth specialty therapies such as ophthalmology, dermatology, cardiology, and pain management. In emerging markets, it offers products in segments like antimalarial, gastrointestinal, antibiotics, and more. In the US generics market, Ajanta Pharma has a select portfolio that includes niche and complex technology products, with 40 ANDA approvals commercialised, 3 tentative approvals, and 21 ANDAs awaiting US FDA approval.

Ajanta Pharma is known for its leadership in multiple molecules and therapeutic segments through its "1st to market" products. The company's state-of-the-art manufacturing facilities, robust R&D department, and adherence to global quality standards contribute to its success. Ajanta Pharma operates seven manufacturing facilities in India, with six producing finished formulations and one dedicated to API manufacturing. The facilities at Paithan and Dahej have been approved by the US FDA and WHO, ensuring high-quality products that meet stringent global standards. The company's focus on innovation and quality has earned it several accolades, cementing its position as a reliable and trusted name in the pharmaceutical industry.